Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors
of the digestive system and has high morbidity and mortality rates. It is essential to search …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading
cause of cancer-related death worldwide. Due to the lack of efficient tools for early detection …

Abstract Background Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) is an
efficient biomarker specific for hepatocellular carcinoma (HCC). Some researchers have …

Background & Aims Prothrombin induced by vitamin K absence-II (PIVKA-II) is a diagnostic
and surveillance marker for HCC mainly used in Asia, and has also been shown to be a …

Background As a promising biomarker of hepatocellular carcinoma (HCC), protein induced
by vitamin K absence or antagonist-II (PIVKA-II) has been studied extensively. However, its …

Objectives: The aim of this study is to assess the usefulness of prothrombin induced by
vitamin K absence or antagonist-II (PIVKA-II) in monitoring of recurrent hepatocellular …

AIM: To determine the cutoff values and to compare the diagnostic role of alpha-fetoprotein
(AFP) and prothrombin induced by vitamin K absence-II (PIVKA-II) in chronic hepatitis B …

Simple Summary Circulating biomarkers for the early detection and prediction of
hepatocellular carcinoma development are an unmet need. In the present study, we …

Abstract Background & Aims Protein induced by vitamin K absence or antagonist‐II (PIVKA‐
II) has been suggested as a serum biomarker for hepatocellular carcinoma (HCC) in Asian …

AIM: To evaluate diagnostic value of α-fetoprotein (AFP)-L3 and prothrombin induced by
vitamin K absence-II (PIVKA-II) in hepatocellular carcinoma (HCC). METHODS: One …